logo
ResearchBunny Logo
Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways

Medicine and Health

Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways

M. Gagne, B. J. Flynn, et al.

This groundbreaking study explores the innovative use of aerosolized RBD-62 to combat SARS-CoV-2 Delta in rhesus macaques, demonstrating its ability to suppress viral replication while preserving immune responses. Conducted by a team of expert researchers, this work offers proof-of-concept for novel therapeutics that could prevent severe illnesses from emerging variants.

00:00
00:00
Playback language: English
Citation Metrics
Citations
0
Influential Citations
0
Reference Count
0

Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny